Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
crispr
5
×
gene editing
life sciences
national blog main
boston blog main
boston top stories
clinical trials
deals
editas medicine
allergan
boston
cancer
car-t
cynthia collins
drugs
gene therapy
national
national top stories
novartis
pfizer
san francisco blog main
abbvie
acquisitions
administration
advanced therapies
alzheimer's
alzheimer's disease
amgen
atmp
avexis
bellicum pharmaceuticals
biogen
biomarin pharmaceutical
biontech
bioprocess insider
bms
boulder/denver blog main
boulder/denver top stories
brammer bio
What
gene
5
×
editing
therapy
crispr
editas
experimental
medicine
abbvie
access
advanced
allergan
alliance
becker
billions
bio
biotech
blessing
bosley
breathing
capacity
car
cell
ceo
check
clinical
close
colossal
companies
company
consolidation
create
crispr’s
cusp
depart
dollars
eaton
exits
falcon
focus
genetic
Language
unset
Current search:
crispr
×
gene
×
biotech
×
@techcrunch.com
2 years ago
How Colossal sold investors on a quest to resurrect a woolly mammoth
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
